Children’s Hospital Colorado is pleased to announce that Michael Verneris, MD, has been named director of Bone Marrow Transplant and Cellular Therapy for the hospital’s Center for Cancer and Blood Disorders (CCBD) at the Anschutz Medical Campus.
Before joining Children's Colorado in October, Dr. Verneris served as vice chair for research and was a tenured professor at the University of Minnesota Medical School, Department of Pediatrics.
"I am absolutely thrilled that Mike has joined us, and I look forward to our acceleration in the advancement of pediatric cancer treatment and research as we work to reimagine child health," said Lia Gore, MD, medical director of the CCBD and Experimental Therapeutics at Children’s Colorado.
Dr. Verneris received a medical degree from the Dartmouth-Brown Program in Medicine and completed a pediatric internship and residency at Children's National Medical Center, followed by a pediatric hematology/oncology fellowship at Stanford University and a post-doctoral fellowship at the Stanford University Division of Bone Marrow Transplant.
He credits the parents of his patients for inspiring his research. The children he sees typically are the highest risk and often need more advanced treatment than traditional patients with cancer. Through his work at the CCBD, Dr. Verneris will continue his research on individualized treatments that help patients’ immune systems recognize cancer and defeat it.
"Parents have asked me questions about their child's disease, and I realize that we don't know the answer, " Dr. Verneris said. "So we go back to the lab and try to figure it out."